Onco-hypertension: Overview of hypertension with anti-cancer agents
Publication
, Journal Article
Ruf, R; Yarandi, N; Ortiz-Melo, DI; Sparks, MA
Published in: Journal of Onco-Nephrology
February 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal of Onco-Nephrology
DOI
EISSN
2399-3707
ISSN
2399-3693
Publication Date
February 2021
Volume
5
Issue
1
Start / End Page
57 / 69
Publisher
SAGE Publications
Citation
APA
Chicago
ICMJE
MLA
NLM
Ruf, R., Yarandi, N., Ortiz-Melo, D. I., & Sparks, M. A. (2021). Onco-hypertension: Overview of hypertension with anti-cancer agents. Journal of Onco-Nephrology, 5(1), 57–69. https://doi.org/10.1177/23993693211001374
Ruf, Rebecca, Niloufarsadat Yarandi, David I. Ortiz-Melo, and Matthew A. Sparks. “Onco-hypertension: Overview of hypertension with anti-cancer agents.” Journal of Onco-Nephrology 5, no. 1 (February 2021): 57–69. https://doi.org/10.1177/23993693211001374.
Ruf R, Yarandi N, Ortiz-Melo DI, Sparks MA. Onco-hypertension: Overview of hypertension with anti-cancer agents. Journal of Onco-Nephrology. 2021 Feb;5(1):57–69.
Ruf, Rebecca, et al. “Onco-hypertension: Overview of hypertension with anti-cancer agents.” Journal of Onco-Nephrology, vol. 5, no. 1, SAGE Publications, Feb. 2021, pp. 57–69. Crossref, doi:10.1177/23993693211001374.
Ruf R, Yarandi N, Ortiz-Melo DI, Sparks MA. Onco-hypertension: Overview of hypertension with anti-cancer agents. Journal of Onco-Nephrology. SAGE Publications; 2021 Feb;5(1):57–69.
Published In
Journal of Onco-Nephrology
DOI
EISSN
2399-3707
ISSN
2399-3693
Publication Date
February 2021
Volume
5
Issue
1
Start / End Page
57 / 69
Publisher
SAGE Publications